PCN51 Comprehensive Investigation of Adverse Event (AE)-Related Costs in Patients With Metastatic Breast Cancer (mBC) Treated With First- and Second-Line Chemotherapies
Nov 1, 2012, 00:00 AM
10.1016/j.jval.2012.08.1244
https://www.valueinhealthjournal.com/article/S1098-3015(12)02957-9/fulltext
Section Title :
Cancer
Section Order :
749
First Page :
A418
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(12)02957-9&doi=10.1016/j.jval.2012.08.1244